Call Toll Free:
1 (855) MEDVIN-1
Lupus (SLE)
We are conducting a clinical trial to evaluate the effectiveness and safety of innovative therapeutic interventions for individuals diagnosed with lupus, also known as systemic lupus erythematosus (SLE). Lupus is a chronic autoimmune disease that can affect multiple organs and systems in the body. This study aims to assess the potential of new treatments in managing lupus symptoms and improving patient outcomes.
PARTICIPATION CRITERIA
Must be at least 18 years of age.
Must have a diagnosis of SLE. within the last 2 years
Must have ongoing disease activity despite medication use.
Must not have any other major medical condition.
PARTICIPATING LOCATIONS
Apple Valley, Riverside, Menifee, Covina, Whittier, Tujunga
Compensation
Earn up $1,900 participating ($100 per visit, 19 visits)
Medications
FDA Approved Drug Benlysta (no placebo). All subjects will receive this FDA approved drug in different dosages
Duration
3 year study (19 visits)
